GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product nabiximols (brand name, Sativex) which was the first natural cannabis plant derivative to gain market approval in any country.[4] Another cannabis-based product, Epidiolex, for treatment of epilepsy, was approved for treatment of epilepsy in 2018. read more
0
Deals
815
Views
Viewed
less than a minute ago
1
Saves
GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product nabiximols (brand name, Sativex) which was the first natural cannabis plant derivative to gain market approval in any country.[4] Another cannabis-based product, Epidiolex, for treatment of epilepsy, was approved for treatment of epilepsy in 2018. read more
815
Views
1
Followers
0
Deals
Sponsor Details
People
People
Deals
Partners
Key Markets
Competitors
Agencies
Analytics
It looks like you're not currently logged in. In order to access this page, please sign in first.
If you currently work at this organization, click the “Do you work here?” button to request editing privileges.
This SponsorPitch page is about GW Pharmaceuticals and contains information about this organization's sponsorship activity, sponsorship decision makers and sponsorship preferences. This page is not endorsed by or affiliated with GW Pharmaceuticals , though it may be actively managed and updated by company representatives. If you currently work at this organization, click the Do you work here button to request management privileges. All trademarks, service marks and copyrights are property of their respective owners.
Please log in to access this feature. Don't have an account? Sign up today!